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Preclinical Analysis of Irreversible Electroporation
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Youn-Suk Choi, Ph.D.,1,2,* Hong-Bae Kim, M.S.,3,* Junho Chung, M.D., Ph.D.,4 Hyung-Sik Kim, M.S.,5
Jeong-Han Yi, Ph.D.,5 and Je-Kyun Park, Ph.D.1
A microfabricated electroporator (MFE) for the irreversible electroporation (IRE) of tissues has been developed
by miniaturizing a clinical electroporator with a two-needle array while keeping the same electric field strength
distribution. Since IRE was brought to special attention as one of the local tissue ablation techniques to treat
tumors, many preclinical studies have been conducted to investigate the efficacy of IRE on animal tissues.
However, some technical difficulties have been frequently encountered due to the macroscale dimension of
clinical electroporators, particularly in experiments on small animal models such as the mouse or rat. Here, the
MFE was proposed to solve the associated problems, resulting in time- and cost-effective experimental proce-
dures. With the developed MFE, the effect of IRE on rat liver tissues was analyzed with time by im-
munohistological stainings and electrical measurement, and the experimental results were compared with those
operated with the corresponding real-scale clinical electroporator.
Introduction
For several decades, electroporation (EP) has beenfound to be an effective technique to enhance the intra-
cellular delivery of target molecules. In EP, multiple transient
nanometer-scale pores are created on the cell membrane
through a dielectric breakdown by applying short and in-
tense electric pulses (a few microsecond to a few millisecond
pulse width, 0.4–1.5 kV/cm). During this electropermeabi-
lized state, mass transport barriers are diminished and for-
eign materials (e.g., drug, gene, enzyme, antibody, and other
biochemical reagents for intracellular assays) can be intro-
duced into cells.1–3 This native feature of EP in enhancing
material transport across the cell membrane has opened up
new applications in medical field such as electrochemo-
therapy or electro gene therapy for the intracellular delivery
of anticancer drugs or genes in living tissues, respectively.3–9
These techniques are known as reversible EP, because electric
pulses are applied in a controlled way for the induced
membrane pores to be resealed after some period of time
and, after which, cells survive well.10 On the contrary, in
other medical applications such as nanosecond pulsed elec-
tric fields or irreversible EP (IRE), electric pulses can cause
irreparable damages to cells to induce programmed cell
death (apoptosis) or necrosis with much harsher electric
pulse conditions than those in the reversible EP. In nano-
second pulsed electric fields, nanosecond-order electric pul-
ses reach the cell interior by penetrating into the cell
membrane and eventually generate cell apoptosis,11 whereas
IRE electroporates the cell membrane permanently and re-
sults in eventual cell death due to the loss of cell homeo-
stasis.12–14
IRE was originally considered as an undesirable effect to
prevent in reversible EP protocols, and studied only to define
the upper limit of electrical parameters that could guarantee
nonlethal reversible EP13,15 and as an effective method to kill
microorganisms in the food industry.16 Only during the last
few years has IRE begun to receive careful attention as an
important local tissue ablation technique to treat tumors. Since
the first preclinical study in 2006,16 IRE has shown to be ef-
fective for ablation of the liver,14,16,17 blood vessel,18,19 tu-
mor,20 heart,21 and prostate22 in small16,18–20 and large animal
models14,17,21,22 without critical thermal damages. Other than
the obvious advantages of simple and fast treatment, IRE
produced a well-defined region of tissue ablation and was not
affected by blood flow. It was reported that IRE spared tissue
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scaffold other than target cells,15 and might be effective even
in immune-depressed cancer patients.20
Although several plate- or needle-type electrode configu-
rations have been widely used in EP-based therapeutic
studies23 depending on the position and size of target tissues,
these clinical electroporators have some technical problems
in preclinical studies due to their macroscale geometry of up
to several tens of millimeters. First, systemic in vivo study
requires many animals to be sacrificed, especially in small
animal models such as the mouse and rat, since only a lim-
ited number of EP lesions can be created within a target
organ. Generally, only 1–3 EP lesions are created in the
mouse or rat, whereas 2–12 lesions are created in large ani-
mal models such as the dog or pig with real-scale clinical
electroporators (RCEs) depending on the relative size of tis-
sues and clinical electroporators. Second, a high-voltage
pulse generator is required for the stable operation of RCEs
with a voltage output over 1 kV and current driving capa-
bility of tens of amperes when plate-pair or needle-array
electrodes are used. This high performance pulse generator is
not only expensive but also requires careful attention during
operation to maintain safety. Third, large tissue sample sizes
could lead to mishandling during the sectioning or fixation
procedures.
To overcome the above-listed technical problems of RCEs
in preclinical study, we have developed a microfabricated
electroporator (MFE) by miniaturizing a clinical electro-
porator having two needles while keeping the same electric
field strength distribution. The feasibility of the proposed
MFE was exploited by applying IRE treatment on rat livers,
and all the experimental outputs of MFE were compared
with those of the corresponding RCE. Immunohistological
changes were inspected within 24 h after IRE by hematoxylin
and eosin (H&E) staining and terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) assay. Electric
current measurements were conducted during the pulse




To design an MFE, the geometry of a clinical electro-
porator having two needle electrodes of 0.5 mm diameter,
10 mm length, and 5 mm center-to-center distance was scaled
down 5:1 (Fig. 1A, B). The poly(dimethylsiloxane) (PDMS)
wire-guide was fabricated by conventional photolithography
and the PDMS replica molding process (Fig. 2A–C)24 to fix
stainless steel wires at right positions. After a patterning of
100-mm-thick SU-8 2050 film (MicroChem, Newton, MA) on
a silicon substrate (Fig. 2A, B), a mixture of PDMS pre-
polymer and curing agent (Sylgard 184; Dow Corning,
Midland, MI) was poured onto the fabricated mold and
cured for 3 h at 608C in a convection oven to complete cross-
linking (Fig. 2C). After peeling off the PDMS wire-guide
from the mold, SUS-304 stainless steel wires of 100 mm di-
ameter (Nilaco, Tokyo, Japan) were tightly fitted onto the
PDMS wire-guide, which had counter grooves of 100 mm
width, and another flat PDMS piece was bonded irreversibly
with it by plasma treatment (200 mTorr, 200 W) for 30 s using
an expanded plasma cleaner (Harrick Plasma, Ithaca, NY)
(Fig. 2D). Figure 2E is the photograph of the MFE.
FIG. 1. Design of an MFE and electric field distribution.
Comparison of (A) RCE with (B) MFE. (C) Simulation results
of electric field distribution. Electric field strength at the
middle of the electrodes is 1 kV/cm. RCE, real-scale clinical
electroporator; MFE, microfabricated electroporator.
FIG. 2. Fabrication process of the PDMS wire-guide in the
MFE. (A) Spin coating of SU-8 2050 photoresist and UV ex-
posure. (B) Patterning of an SU-8 layer. (C) PDMS replica
molding. (D) Installation drawing. (E) Photograph of the
MFE. PDMS, poly(dimethylsiloxane).
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An RCE was made by fixing 25-gauge syringe needles in a
custom-made polymer piece having two holes of 0.5 mm
diameter with 5 mm center-to-center distance. The MFE and
RCE have the same electric field strength distribution as
depicted in the simulation results of Figure 1C. The steady
state electric field distribution was obtained by solving the
Laplace equation,
r2¼ 0, (1)
where F is the electric potential, with a commercial sim-
ulation package (CFD-ACEþ ; ESI-CFD, Huntsville, AL).
The liver tissue around RCE was modeled as a cylinder of
20 mm diameter and 25 mm height, and then the model was
proportionally scaled down for the case of MFE. Fixed
electric potential boundary condition was applied on the
electrode surfaces, and the remaining outer surfaces were
treated as electrically insulating. Despite the fact that the
electric field changed somewhat along the electrode length,
typical 1 kV/cm electric field strength was obtained at the
middle of electrodes with voltage amplitudes of 150 and
750 V for MFE and RCE, respectively (which also maintained
1:5 ratio).
Irreversible electroporation
This study was approved by the Institutional Animal Care
and Use Committee at the Seoul National University College
of Medicine. Eight-week-old male Sprague-Dawley rats
weighing 250–350 g were used, and all animals received
humane care in compliance with the institutional guidelines
of Seoul National University and current international laws
and policies.25 Rats were maintained at a controlled room
temperature (248C) with a natural day/night light cycle in a
conventional animal colony and fed food and water ad libi-
tum. They were adapted for 2 weeks to these conditions
before testing.
Liver was exposed via midline incision after anesthetiza-
tion with intraperitoneal injection of 10 mg/kg Zoletil (Vir-
bac, Carros, France) solution. Electrodes were then inserted
into the liver, and eight rectangular direct current pulses of
100 ms width were applied at a frequency of 1 Hz with volt-
age amplitudes of 150 V for MFE and 750 V for RCE using a
laboratory-built pulse generator to get nominal electric field
strength of 1 kV/cm at the middle of the electrodes. Up to
four IRE lesions were created in a lobe for MFE, with keeping
over 10 mm distance between each lesion to isolate each le-
sion from the effect of electric pulses of neighboring lesions,
while only one IRE lesion could be created in a lobe for RCE
due to the limited liver size. Every IRE treatment was con-
ducted with new electrodes to exclude any unexpected re-
sults due to the electrochemical change on electrode surfaces.
After the IRE treatment, skin incisions were sutured and the
animals were kept alive up to 24 h. Liver tissues were sam-
pled after 3, 10, 17, and 24 h of IRE, and the rats were eu-
thanized. Liver samples were fixed in 10% (v/v) formalin
solution, dehydrated, embedded in paraffin, and then sec-
tioned in an axial cut through a plane normal to the electrode
length direction. After mounting the samples on slides, H&E
staining was performed to elucidate necrosis and cell apo-
ptosis was also assessed by TUNEL assay kit (S7100; Mill-
opore, Temecula, CA).
To quantify the degree of cell apoptosis, the percentage of
stained area in TUNEL assay images was calculated, as
previous area-based evaluation method in TUNEL assay,26,27
within a circular area around the electrodes (1-mm-diameter
circle for MFE and 5-mm-diameter circle for RCE) by deter-
mining the area that was at least 25% darker than nonstained
normal tissue area after converting the color images into
gray-scale images. Image analysis was performed with Im-
ageJ (http://rsb.info.nih.gov/ij/).
Electric current was measured and digitized during the
application of eight electric pulses of 100 ms width and 5 kHz
frequency using a current probe (TCPA300; Tektronix, Bea-
verton, OR) and a digital oscilloscope (TDA3044B; Tektronix)
to observe the current change in tissues during EP. The same
voltage amplitudes were used as the IRE operation, and all
measurements were carried out in triplicate by moving into a
new nontreated position each time. At the pulse frequency of
5 kHz, the fraction and resealing time of long-lived pores,28,29
and the cell viability after EP could be different from those
with 1 Hz pulses. Although the influence of frequency
should be validated further, we expected that the current
measurement with 5 kHz pulses was reasonable for com-
paring the electric characteristic of MFE with that of RCE
since they underwent the same frequency effect.
Thermal simulation
Temperature distribution in liver tissue was analyzed
numerically with CFD-ACEþ for the characterization of
Joule heating effect of electric pulses. Time-dependent tissue
temperature, T, was computed by Pennes bioheat equation30
with an additive Joule heating source term,12,31




where k (0.512 W m1 K1, Dk/k/DT¼ 0.25% 8C1) is the
thermal conductivity of the tissue, wb (1 kg m
3 s1) is the
blood perfusion, cb (3640 J kg
1 K1) is the heat capacity of
the blood, Ta (378C) is the arterial temperature, qm
(33800 W m3) is the metabolic heat generation, qj is the Joule
heat, r (1050 kg m3) is the tissue density, cp (3600 J kg
1 K1)
is the heat capacity of the tissue, and t is the time. After
solving the Laplace equation (Eq. 1), Joule heating (qj) was
calculated by
qj¼ rjrj2 (3)
where s (0.286 S m1, Ds/s/DT¼ 1.5% 8C1) is the electrical
conductivity of the tissue. The tissue properties were taken
from the references.12,32–34 The change of electrical conduc-
tivity caused by electropermeabilization and pore resealing
was not considered.
Two-dimensional grids of 9028 triangles and rectangles
were used to model an upper semicircular geometry, which
included an IRE lesion and its surrounding tissue, having a
five times larger diameter than center-to-center electrode
distance. The bottom line of the upper semicircle was set to
symmetric boundary condition. Fixed electric potential was
applied on electrode surfaces with the same experimental
IRE pulse condition, and outer borders were electrically in-
sulating. All the outer borders and electrode surfaces were
thermally adiabatic. It was assumed that the tissue was
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initially at the physiological temperature of 378C. Implicit
time integration scheme was used with time steps of 10ms
during the pulses, and 0.01 s between and after the pulses.
Statistical analysis
The differences between the mean values of groups were
tested for significance by t-test after one-way analysis of vari-
ance was performed and fulfilled for all experimental data.
The p-values less than 0.05 were considered significant. All
mean values were obtained from at least three experiments.
Results and Discussion
Some mild degree of muscle contractions occurred during
the pulse application even without any usage of muscle re-
laxant, and most of the rats tolerated the procedure and
survived well. Nevertheless, the muscle contractions seemed
to be more severe for the case of RCE than MFE, and it might
be related to the one order of magnitude electric current
difference between them. Electrode stiffness in the MFE was
sufficient to puncture the rat liver, and mechanical failure
such as buckling was not observed.
Macroscopic changes after IRE
Macroscopic images were obtained with H&E staining
and TUNEL assay after 3, 10, 17, and 24 h of IRE operated
with MFE and RCE, as shown in Figure 3. Clear borders
were observed between IRE-treated and nontreated regions
in H&E staining images throughout the observation time,
while time-dependent apoptotic labeling patterns were ob-
tained in the TUNEL assay images. These clear borders in
H&E staining images were mainly attributed to pale eosino-
philic cytoplasms in the treated region. Figure 4 shows the
percentage of stained area in TUNEL assay with time. After
3 h of IRE, apoptotic cells were not fully labeled in TUNEL
assay, despite that the IRE-treated regions were definitely
distinguished from the nontreated regions both in the H&E
staining and TUNEL assay images. TUNEL assay labeling
reached maximum after 10 h of IRE and decreased thereafter.
Stronger IRE pulse condition would be necessary for the
complete tissue ablation judging from the maximum 35%
stained area at most (Fig. 4), while the pulse protocol used in
this study has been known to be sufficiently effective in
electrochemotherapy.35 Entire labeling patterns with MFE
FIG. 3. Macroscopic images of H&E staining (left images) and TUNEL assay (right images) in the MFE and the RCE,
respectively. Images were obtained after 3, 10, 17, and 24 h of IRE operated with MFE or RCE. H&E, hematoxylin and eosin;
TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling; IRE, irreversible electroporation. Color images
available online at www.liebertonline.com/ten.
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and RCE were quite similar until 10 h. However, the per-
centage of stained area showed steeper decrease in the case
of MFE than that of RCE after 17 h of IRE. We speculate that
this rapid decreasing rate of apoptotic cell labeling with MFE
could be related to the speed of wound healing process after
IRE. Irrespective of geometric proportionality, the absolute
size of IRE lesion of MFE was much smaller than that of RCE,
and this smaller IRE-affected area of MFE seemed to facilitate
a faster wound healing than RCE as seen in microscopic im-
ages (Fig. 5). This will be further looked into in the following
section on microscopic changes after IRE. Even though there
was some discrepancy in TUNEL assay after 17 h of IRE, the
relative extent and shape of the IRE-treated regions to elec-
trode geometry, and the degree of apoptotic cell labeling until
10 h exhibited similar results between MFE and RCE.
Microscopic changes after IRE
As discussed with the macroscopic images (Fig. 3), mi-
croscopic histologies exhibited sharp borders between IRE-
treated and nontreated regions both in H&E stainings and
TUNEL assays. The borders were obviously observed in
H&E stainings irrespective of inspection time within 24 h of
IRE and revealed acute damages in the IRE-treated tissues,
whereas TUNEL assay after 10 h of IRE showed the clearest
margination (Fig. 6A, B). Widespread pale eosinophilic cy-
toplasms (Fig. 6C, D) and congestion in sinusoids (Fig. 5B)
were found in the treated zones, and these were the two
main histological symptoms that distinguished the treated
tissues from the nontreated normal tissues. Cell borders were
clearly visible on the nontreated healthy parenchymas (Fig.
5A), whereas they were partly or totally ambiguous in the
treated sides depending on the inspection time, which sug-
gested cellular degeneration was underway. Other typical
evidence of IRE treatment such as pyknosis of nuclei, vacu-
olar degeneration, massive diapedesis, and fibrin deposition
in blood vessels was also observed in the treated sides
(Fig. 5B, C). Endothelial damages, especially for small blood
vessels, were present in the treated sides with the traces of
hemorrhage (Fig. 5B, C), whereas blood vessels were intact in
the nontreated sides (Fig. 5A). These histological signs,
which would lead to the eventual death of hepatocytes, were
in accordance with those that had been reported in the pre-
vious IRE studies on animal livers.14,16,17
As cell apoptosis progressed, inflammatory cells started to
gather on the border between the damaged and nondamaged
regions, and infiltrated gradually into the central damaged
region hereafter. This phenomenon was observed from 10 h
after IRE (Fig. 5D, E). After 17 h of IRE, inflammatory cells were
crowded near the boundary of the treated region (see arrows in
Fig. 5F, G), and they were also found after 24 h of IRE when
the TUNEL assay staining was blurred in a great measure
(Fig. 5H, I). These findings explain that the IRE-induced cell
death was progressed with the immune cell-derived phago-
cytosis of apoptotic cells. In case of MFE, inflammatory cells
moved easily from the boundary into the central of IRE-treated
zone due to the short span of the lesion, and no traces of liver
parenchyma could be seen after 24 h of IRE (Fig. 5H). On the
other hand, segregated groups of inflammatory cells were
observed sporadically after 24 h of IRE in case of RCE (Fig. 5I),
and traces of cell borders were still found, though obscure, near
the center of the IRE lesions, whereas they almost disappeared
in the outer marginations (data not shown). This difference in
the infiltration capability of inflammatory cells was supposed
to bring about the difference in the apoptotic cell labeling of
TUNEL assays after 17 h of IRE in Figure 4. However, further
studies are required to make clear and elucidate the difference
of long-term healing process.
It is hard to prescribe the exact electric pulse condition re-
quired to induce sufficient IRE damage due to the variance of
experimental results. Nonetheless, we could find that MFE
and RCE had similar threshold electric field strength of around
0.7 kV/cm in rat liver tissues with the H&E staining images
superposed with iso-electric field curves (Fig. 6C, D), and this
value was very similar to that of previous reports.14,36,37
Electric current measurement
Measured electric currents are plotted in Figure 7A. Al-
though the three-dimensional electric simulation predicted
that the electric current through RCE should be 25-fold
higher than that through MFE, actual measured values did
not show such a big difference since the relatively long
electrodes of RCE compared with liver tissue went through
the liver tissue completely and did not have sufficient contact
area with the liver tissue for current flow. During the pulse
application, electric current increased gradually as previous
reports in cell pellets28,38 or tissues.39 The electric pulses
opened up nanometer-scale pores on the cell membrane, and
resulted in higher electrically conductive state of the tissues.
Although the current increase might be caused by both re-
versible and irreversible EP within the affected area, more
experiments such as long-term impedance analysis are re-
quired for in-depth examination. The fact that this current
increase was caused by EP on the live cell’s membrane was
further confirmed with additional current measurements in
normal saline and pork piece, whose cell viability might be
lost, and both of them did not make any current increases
(data not shown). The quantity of current increase could be
seen more clearly when the mean current of specific pulse was
plotted after normalizing by the mean current of the first pulse
(Fig. 7B). No statistical difference was found in the current
increase between MFE and RCE, and the current increase
amounted to as much as 10% at the eighth electric pulse.
FIG. 4. Percentage of the stained area in TUNEL assays.
Color images available online at www.liebertonline.com/ten.
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Comparison of thermal effects on tissue-based IRE
Temperature distribution right after the end of the eighth
pulse is shown in Figure 8A. Although electrode surfaces
exhibited highly localized temperature rise with concen-
trated electric field strength, most tissue was maintained
below 408C. The average temperature in RCE case was
somewhat higher than that in MFE, particularly near the
electrodes. Thermal histories at points ‘‘a’’ in Figure 8A
showed a cycle of temperature rise and drop with the pulse
application, and a little higher maximum temperature was
obtained with RCE (Fig. 8B). This rather higher temperature
level with RCE might be attributed to slower heat dissipation
depending on the size difference of IRE lesions. In a cylin-
FIG. 5. Microscopic images of H&E staining
in the MFE (B, D, F, H) and the RCE (C, E, G,
I), respectively. Images were obtained in
normal liver tissue (0 h; A) and after 3 (B, C),
10 (D, E), 17 (F, G), and 24 h (H, I) of IRE.
Arrows indicate the aggregated inflamma-
tory cells. tr, IRE-treated region; nt, IRE-
nontreated region. Color images available
online at www.liebertonline.com/ten.
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drical IRE lesion, whose diameter is the center-to-center
electrode distance and height is the electrode length of a two-
needle electroporator, heat dissipation rate versus total heat
generation is proportional to the surface-to-volume ratio of
the cylinder, assuming that the heat exchange with a sur-
rounding tissue is dominated by thermal conduction. Since
RCE and MFE generate the same volumetric Joule heat (qj)
under the same electric field, the heat dissipation in a lesion
of MFE is five times faster than that of RCE under the 1:5
geometric ratio. Even though RCE seemed to be more prone
to heat up the tissue, the maximum temperature was below
508C, from which the tissue damage is known to increase
rapidly.40 Over 98% of the area within a circular area around
the electrodes still remained below 408C both in RCE and
MFE, and even the accumulated heat diffused out within a
few seconds. Judging from these, tissues might experience
negligible thermal effect in RCE as well as MFE.
The numerical results might underestimate the tempera-
ture rise because, in real situation, the electrical conductivity
of the tissue increased during EP. On the other hand, there
are also various other factors to affect the thermal distribu-
tion in tissue-based EP. Tissue surfaces exposed to atmo-
sphere may facilitate enhanced cooling by convective heat
transfer, and electrode may act as a heat sink or source with
its own thermal mass or Joule heating. To understand the
effect of those factors in detail, the development of robust
simulation model reflecting sufficient experimental data
would be necessary.36,37
The rat liver tissues operated with MFE and RCE resulted
in almost the same details in histology within 24 h after IRE
as well as electrical change during the pulse application,
whereas MFE exhibited a faster infiltration capacity of in-
flammatory cells than RCE. To definitely determine the
limitation or extend the applicability of MFE, further post-
IRE inspection would be necessary to compare the long-term
tissue regeneration process. However, even in the current
FIG. 6. Histology in IRE lesions.
(A, B) TUNEL assay images at the
boundary of IRE lesion after 10 h of IRE
operated with MFE and RCE, respectively.
(C, D) H&E staining images after 3 h of
IRE superposed with iso-electric field
curves for the case of MFE and RCE,
respectively. Color images available online
at www.liebertonline.com/ten.
FIG. 7. Experimental results of current measurement. (A)
Current change with applying electric pulses. (B) Normal-
ized mean current (i.e., the mean current of pulse normalized
by the mean current of the first pulse). Color images avail-
able online at www.liebertonline.com/ten.
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state, it may be useful in the study of IRE technique not only
to clarify the early stage efficacy, but also to find a novel
electrode configuration and the corresponding pulse mode.
Of the various factors, determining the optimal electric
condition to fully ablate target tissues and the maximum
span to which electric pulses can exert a powerful influence
are very important in clinics. However, systemic studies
have not been done in IRE as with regard to these issues, and
this could be a potential application of the proposed device,
particularly for needle-type electroporators. From a different
viewpoint, rapid prototyping methods for fabricating other
types of electrode configurations should be further devised
to extend the applicability of the MFE.
Conclusions
A proportionally miniaturized device of a clinical electro-
porator having two needles was developed by using micro-
fabrication technology and successfully applied to the
preclinical IRE study on rat liver tissues. The proposed device
could reflect the characteristics of clinical electroporator quite
well with regard to immunohistology and current increase
during EP, while its assay procedure was more efficient in
terms of time and cost than that with the corresponding RCE.
Many studies have been rigorously executed for the various
EP-based therapies such as IRE, electrochemotherapy, electro
gene therapy, and nanosecond pulsed electric fields to ex-
amine the effect of the treatments and to set up the standard
operating procedures since EP was recognized as one of the
plausible methodologies to ablate tumors locally. However,
there are still lots of tasks that should be unveiled for the
successful clinical applications not only in empirical aspect but
also in basic theoretical aspect. In this respect, we expect that
the proposed MFE can serve as an enabling tool in the pre-
clinical studies of EP-based therapies to reduce the required
research resources and endeavor.
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